Hot Stocks: Brokerages on PVR, TVS Motor and Gland Pharma
indiatimes.com
economics
2022-10-18 07:15:00

Global brokerage firm Morgan Stanley initiated coverage on with an overweight rating, CLSA retained a buy rating on PVR, and UBS maintained its buy recommendation on . 
We have collated a list of recommendations from top brokerage firms from ETNow and other sources:

Morgan Stanley on Gland Pharma: Overweight| Target Rs 2,748Morgan Stanley initiated coverage on Gland Pharma with an overweight rating and a target price of Rs 2,748. The company has a strong balance sheet, and it has already gone through a sharp 45% year-to-date (YTD) stock price correction, said Morgan Stanley.
